Hadi Poormoghim

Hadi Poormoghim

Auto-generated profile, based on publicly available information

Hadi Poormoghim

Department of Rheumatology, Firoozgar Hospital - Beh Afarin street, Tehran, Iran

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 November 2022 in Scientific Reports
Verified
Journal Article
Open access
PDF file
PBParia Bayati
Paria Bayati
MKMahsa Kalantari
Mahsa Kalantari
MAMohammad-Ali Assarehzadegan
Mohammad-Ali Assarehzadegan
HPHadi Poormoghim
Hadi Poormoghim
NMNazanin Mjtabavi
Nazanin Mjtabavi
Systemic sclerosis (SSc) or scleroderma is a multiorgan rheumatoid disease characterized by skin tightening or organ dysfunction due to fibrosis, vascular damage, and autoimmunity. No specific cause has been discovered for this illness, and hence no effective treatment exists for it. On the other hand, due to the lack of diagnostic biomarkers capable of effectively and specifically differentiating the patients, early diagnosis has not been possible. Due to their potent regulatory roles in molecular pathways, microRNAs are among the novel candidates for the diagnosis and treatment of diseases like SSc. MiR-27a is a microRNA known for its role in the pathogenesis of fibrosis and cancer, both of which employ similar signaling pathways; hence we hypothesized that Mir-27a could be dysregulated in the blood of individuals affected by SSc and it might be useful in the diagnosis or treatment of this disease. Blood was collected from 60 SSc patients (30 limited and 30 diffuse) diagnosed by a rheumatologist according to ACR/AULAR criteria; following RNA isolation and cDNA synthesis; real-time qPCR was performed on the samples using Taq-Man probes and data were analyzed by the ΔΔCT method. Also, potential targets of miR-27a were evaluated using bioinformatics. It was revealed that miR-27a was significantly down-regulated in SSc patients in comparison to healthy individuals, but there was no difference in miR-27 expression between limited and diffused SSc patients. Besides, miR-27a was found to target several contributing factors to SSc. It seems that miR-27a has a protective role in SSc, and its downregulation could result in the disease's onset. Based on bioinformatics analyses, it is speculated that miR-27a likely targets factors contributing to the pathogenesis of SSc, which are elevated upon the downregulation of miR-27a; hence, miR-27a mimics could be considered as potential therapeutic agents for the treatment of SSc in future studies. Since no difference was observed between limited and diffuse patient groups, it is unlikely that this microRNA has a role in disease progression. According to ROC analysis of qPCR data, miR-27a could be employed as a valuable diagnostic biomarker for SSc.

9 April 2024 in European Journal of Internal Medicine
Verified
Journal Article
Closed access
Alina DimaAlina Dima
Alina Dima
MVMC Vonk
MC Vonk
AGA Garaiman
A Garaiman
BKBe Kersten
Be Kersten
RBR Becvar
R Becvar
CMC Mihai
C Mihai

27 February 2026 in Rheumatology
Verified
Journal Article
Open access
PDF file
MSMaryam Salimi-Beni
Maryam Salimi-Beni
LALeila Azizi
Leila Azizi
MMMaryam Mohebi
Maryam Mohebi
NMNegin Mohtasham
Negin Mohtasham
AKAli Kabir
Ali Kabir
HPHadi Poormoghim
Hadi Poormoghim
Objectives: Impaired microvascular function has been implicated as a complication affecting multi­ple organs in systemic sclerosis (SSc). We investigated the correlation between microvascular damage on nailfold video capillaroscopy (NVC) and cardiac arrhythmias or conduction blocks in patients with primary heart involvement (pHI). Material and methods: One hundred ten patients with SSc underwent an NVC study. Thirty-one patients with arrhythmias or conduction blocks were included in the study group. No patients in this group had pulmonary arterial hypertension, systemic hypertension, or ischemic heart disease. Seventy-nine patients with no arrhythmia or block were included in the control group. Qualitative, quantitative, and semi-quantitative capillaroscopic parameters were compared between the 2 groups. Results: In the qualitative NVC analysis the odds ratio (OR) for the early pattern in groups of patients with and without a cardiac outcome was 0.93 (95% CI: 0.35–2.45; p = 0.89). The ORs for the active and late patterns in the 2 groups of patients were 0.92 (95% CI: 0.37–2.30, p = 0.86) and 1.07 (95% CI: 0.52–2.19; p = 0.84), respectively. Semi-quantitative assessment in 6 NVC parame­ters showed that the mean score for capillary density was higher in the outcome group than in the non-outcome group (mean ±standard deviation: 2.19 ±0.910 vs. 1.72 ±1.120; p = 0.04). Capillary disorganization also showed a higher score in patients with cardiac involvement than in those without (1.00 ±0.01 vs. 0.95 ±0.221, p = 0.001). Low capillary density in NVC was associated with sensitivity (Se) of 96.7%, and specificity (Sp) of 18.9%. Disorganized capillaries showed Se of 96.7% and Sp of 5%. However, no significant differences were observed in enlarged capillaries, giant capillaries, microhemorrhages, or ramifications. Conclusions: Lower capillary density and greater disorganization are associated with arrhythmias and conduction blocks in SSc-PHI. The quantitative capillaroscopic parameters were comparable between patients with arrhythmias due to SSc-PHI and those in the non-outcome group. A detailed semi-quantitative capillaroscopic assessment is recommended in scleroderma patients.